ClinicalTrials.Veeva

Menu

Assessment of Three Basic Progressive Lens Designs

W

Western University of Health Sciences (WESTERN U)

Status

Completed

Conditions

Presbyopia

Treatments

Device: Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating

Study type

Interventional

Funder types

Other

Identifiers

NCT05252871
P21/IRB/065

Details and patient eligibility

About

This clinical trial investigates the differences between three different progressive addition lens designs. It is a non-invasive double-masked randomized clinical investigation. For this study, 80 participants will be recruited.

Full description

The purpose of the study is to evaluate the preference, adaptability, and visual performance of three progressive lens designs. The difference in these lens designs is a variation of zone sizes for intermediate and near vision. The clinical trial helps manufacturers and eye care practitioners to give detailed suggestions to patients. Study participants will be experienced progressive addition lens wearers, which will be recruited by advertisements, by email, and with direct person-to-person solicitation. The study will be conducted at the Eye Care Institute at the Patient Care Center Western University of Health Sciences, Pomona, CA, 91766. For each participant, the study is completed in around two months and requires three separate visits.

Enrollment

80 patients

Sex

All

Ages

45 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age: 45 to 70 years old.

  • Visual Acuity: far & near monocular: cc ≥ 20/20 (decimal cc ≥ 1.0)

  • Normal binocular vision (at distance & near: no strabismus on cover testing, aligning prism of less than 2Δ horizontally or vertically, stereoacuity of 2' or better at distance and near).

  • Prescription is in the range:

    • Spherical power: less than +/-6.00 D
    • Cylindrical power: less than -2.75 D
    • Addition: 1.50 D - 2.50 D
    • Difference in power (spherical equivalent) between eyes: less than 2.00 D

Exclusion criteria

  • Have never worn any progressive lens design.
  • First prescription for progressive lenses.
  • Prescription found during visit#1 varies from current prescription more than 0.50 D in any meridian.
  • Currently wearing single vision lenses with accommodative support.
  • Double vision or prismatic prescription in current glasses.
  • Known ocular disease including strabismus, any pathology, any eye surgeries that may affect visual acuity.
  • Use of systemic or ocular medications that are likely to affect vision.
  • Balance problem/vertigo problem.
  • Concurrent participation in other vision-related research.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

80 participants in 2 patient groups

Experimental: The specified PAL design wearers
Experimental group
Description:
Subjects who have been already wearing any from specified design type of PAL
Treatment:
Device: Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating
The other PAL design wearers
Active Comparator group
Description:
Subjects who have been already wearing any from the other design type of PAL
Treatment:
Device: Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems